Related Experiment Video
Updated: Jun 23, 2026

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
Published on: October 22, 2014
Clinical and angiographic factors associated with asymptomatic restenosis after percutaneous coronary intervention
P N Ruygrok1, M W Webster, V de Valk
1Cardialysis, Westblaak 92, 3012 KM Rotterdam, Netherlands. pruygrok@ahsl.co.nz
Insights
About half of patients with angiographic restenosis after percutaneous coronary intervention experience no symptoms. Male sex, larger vessel diameter, and less severe lesions predict silent restenosis.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Biology
Background:
- Angiographic restenosis is a common complication following percutaneous coronary intervention (PCI).
- Distinguishing between asymptomatic and symptomatic restenosis is crucial for patient management.
- Previous studies have explored factors influencing restenosis, but a comprehensive analysis of silent restenosis is needed.
Purpose of the Study:
- To compare clinical and angiographic factors associated with asymptomatic versus symptomatic restenosis after PCI.
- To identify predictors of silent restenosis in patients undergoing coronary revascularization.
Main Methods:
- Analysis of pooled data from 10 major clinical trials (BENESTENT I, II, MUSIC, WEST 1, DUET, FINESS 2, FLARE, SOPHOS, ROSE).
- Inclusion of 2690 patients with angiographic restenosis and 6-month follow-up angiography.
- Multivariate analysis of 46 clinical and angiographic variables to identify predictors of asymptomatic restenosis.
Main Results:
- Restenosis occurred in 607 patients, with 55% being clinically silent.
- Univariate predictors of asymptomatic restenosis included male sex, absence of nitrate/calcium channel blocker therapy, greater reference diameter, and lesser lesion severity.
- Multivariate analysis identified male sex, greater follow-up reference diameter, and lesser 6-month lesion severity as independent predictors of silent restenosis.
Conclusions:
- Approximately half of patients with angiographic restenosis remain asymptomatic.
- Male sex, larger reference vessel diameter at follow-up, and less severe lesion at 6-month angiography are key predictors of silent restenosis.
- These findings may aid in risk stratification and personalized follow-up strategies for patients post-PCI.
Background:
Angiographic restenosis after percutaneous coronary interventional procedures is more common than recurrent angina. Clinical and angiographic factors associated with asymptomatic versus symptomatic restenosis after percutaneous coronary intervention were compared.
Methods And Results:
All patients with angiographic restenosis from the BENESTENT I, BENESTENT II pilot, BENESTENT II, MUSIC, WEST 1, DUET, FINESS 2, FLARE, SOPHOS, and ROSE studies were analyzed. Multivariate analysis evaluated 46 clinical and angiographic variables, comparing those with and without angina. The 10 studies recruited 2690 patients who underwent percutaneous revascularization and 6-month follow-up angiography (86% of those eligible). Restenosis (>/=50% diameter stenosis) occurred in 607 patients and was clinically silent in 335 (55%). Male sex (P=0.008), absence of antianginal therapy with nitrates (P=0.0002) and calcium channel blockers (P=0.02) at 6 months, greater reference diameter after the procedure (P=0.04), greater reference diameter at follow-up (P=0.004), and lesser lesion severity (percent stenosis) at 6 months (P=0.0004) were univariate predictors of asymptomatic restenosis. By multivariate analysis, only male sex (P=0.04), greater reference diameter at follow-up (P=0.002), and lesser lesion severity at 6 months (P=0.0001) were associated with restenosis without angina.
Conclusions:
Approximately half of patients with angiographic restenosis have no symptoms. The only multivariate predictors of silent restenosis at 6 months were male sex, greater reference diameter at follow-up, and lesser lesion severity on follow-up angiography.
Related Concept Videos
Pre-Procedural Guidelines for Assessing Blood Pressure
Assessment of the Cardiovascular System III: Palpation
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above the...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease V: Postoperative Nursing Management
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

